Search

Displaying results 3071 - 3080 of 7284 in total
  1. Drug

    Tifurac

    go.drugbank.com/drugs/DB21415
    Experimental

    Tifurac has a monoisotopic molecular weight of 326.06 Da. … Tifurac is a small molecule drug. The usage of the INN stem '-ac' in the name indicates that Tifurac is a anti-inflammatory agent, ibufenac derivative.

  2. Drug

    Pilavapadin

    go.drugbank.com/drugs/DB21552
    Investigational

    Pilavapadin has a monoisotopic molecular weight of 385.18 Da. … Pilavapadin is a small molecule drug. Pilavapadin is under investigation in clinical trial NCT06203002 (A Dose-ranging Study in Patients With Diabetic Peripheral Neuropathic Pain (DPNP)).

  3. Drug

    Canocapavir

    go.drugbank.com/drugs/DB21570
    Experimental

    Canocapavir has a monoisotopic molecular weight of 561.08 Da. … Canocapavir is a small molecule drug. The usage of the INN stem '-capavir' in the name indicates that Canocapavir is a viral capsid and nucleocapsid inhibitor.

  4. Drug

    Emzeltrectinib

    go.drugbank.com/drugs/DB21605
    Experimental

    Emzeltrectinib has a monoisotopic molecular weight of 376.13 Da. … Emzeltrectinib is a small molecule drug. The usage of the INN stem '-trectinib' in the name indicates that Emzeltrectinib is a tropomyosin receptor kinase (TRK) inhibitor.

  5. Drug

    Zavondemstat

    go.drugbank.com/drugs/DB21608
    Experimental

    Zavondemstat has a monoisotopic molecular weight of 431.22 Da. … Zavondemstat is a small molecule drug. The usage of the INN stem '-demstat' in the name indicates that Zavondemstat is a Lysine-specific histone demethylase inhibitor.

  6. Drug

    Levamlodipine

    go.drugbank.com/drugs/DB09237
    ApprovedInvestigational

    [A188940] Levamlodipine was granted FDA approval on 19 December 2019.[L10833] … [L10833] This medication was first marketed in Russia and India before being granted FDA approval.

  7. Drug

    Icodextrin

    go.drugbank.com/drugs/DB00702
    ApprovedInvestigational

    It is injected as a solution into the peritoneal cavity. The drug is absorbed via convective transport via peritoneal lymphatic pathways.

    Mixtures: SOLUCIÓN DP PISA DXTCategories: Compounds used in a research, industrial, or household setting
  8. Drug

    Pazopanib

    go.drugbank.com/drugs/DB06589
    ApprovedInvestigational

    Pazopanib is a small molecule inhibitor of multiple protein tyrosine kinases with potential antineoplastic activity. It is developed by GlaxoSmithKline and was FDA approved on October 19, 2009.

    Categories: P-glycoprotein substrates with a Narrow Therapeutic Index, Cytochrome P-450 CYP1A2 Substrates with a Narrow Therapeutic Index
  9. Target

    NADH dehydrogenase [ubiquinone] iron-sulfur protein 8, mitochondrial

    go.drugbank.com/bio_entities/BE0000037
    TargetHumans

    Essential for the catalytic activity and assembly of complex I (PubMed:22499348) … Core subunit of the mitochondrial membrane respiratory chain NADH dehydrogenase (Complex I) which catalyzes electron transfer from NADH through the respiratory chain, using ubiquinone as an electron acceptor

    Synonyms: Complex I-23kD
  10. Target

    NADH dehydrogenase [ubiquinone] iron-sulfur protein 6, mitochondrial

    go.drugbank.com/bio_entities/BE0000093
    TargetHumans

    Accessory subunit of the mitochondrial membrane respiratory chain NADH dehydrogenase (Complex I), that is believed not to be involved in catalysis. … Complex I functions in the transfer of electrons from NADH to the respiratory chain. The immediate electron acceptor for the enzyme is believed to be ubiquinone

    Synonyms: Complex I-13kD-A